Literature DB >> 33409766

Management of late onset urea cycle disorders-a remaining challenge for the intensivist?

S Redant1, A Empain2, A Mugisha1, P Kamgang3, R Attou1, P M Honoré4, D De Bels1.   

Abstract

BACKGROUND: Hyperammonemia caused by a disorder of the urea cycle is a rare cause of metabolic encephalopathy that may be underdiagnosed by the adult intensivists because of its rarity. Urea cycle disorders are autosomal recessive diseases except for ornithine transcarbamylase deficiency (OTCD) that is X-linked. Optimal treatment is crucial to improve prognosis. Main body We systematically reviewed cases reported in the literature on hyperammonemia in adulthood. We used the US National Library of Medicine Pubmed search engine since 2009. The two main causes are ornithine transcarbamylase deficiency followed by type II citrullinemia. Diagnosis by the intensivist remains very challenging therefore delaying treatment and putting patients at risk of fatal cerebral edema. Treatment consists in adapted nutrition, scavenging agents and dialysis. As adults are more susceptible to hyperammonemia, emergent hemodialysis is mandatory before referral to a reference center if ammonia levels are above 200 µmol/l as the risk of cerebral edema is then above 55%. Definitive therapy in urea cycle abnormalities is liver transplantation.
CONCLUSION: Awareness of urea cycle disorders in adults intensive care units can optimize early management and accordingly dramatically improve prognosis. By preventing hyperammonemia to induce brain edema and herniation leading to death.

Entities:  

Keywords:  Dialysis; Hyperammonemia; Scavenging therapy; Urea cycle disorders

Year:  2021        PMID: 33409766     DOI: 10.1186/s13613-020-00797-y

Source DB:  PubMed          Journal:  Ann Intensive Care        ISSN: 2110-5820            Impact factor:   6.925


  56 in total

1.  Late-onset urea cycle disorder in adulthood unmasked by severe malnutrition.

Authors:  Diana L Wells; Jillian B Thomas; Gordon S Sacks; L Anna Zouhary
Journal:  Nutrition       Date:  2013-12-16       Impact factor: 4.008

Review 2.  Hepatic Encephalopathy.

Authors:  Eelco F M Wijdicks
Journal:  N Engl J Med       Date:  2016-10-27       Impact factor: 91.245

3.  The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort.

Authors:  Peter J Meffert; Katja D Repp; Henry Völzke; F Ulrich Weiss; Georg Homuth; Jens P Kühn; Markus M Lerch; Ali A Aghdassi
Journal:  J Hepatol       Date:  2017-12-11       Impact factor: 25.083

4.  Recurrent liver failure in a 25-year-old female.

Authors:  Jefrey Salek; Janice Byrne; Terry Box; Nicola Longo; Norman Sussman
Journal:  Liver Transpl       Date:  2010-09       Impact factor: 5.799

5.  Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid.

Authors:  Varsha Thakur; C Anthony Rupar; David A Ramsay; Ram Singh; Douglas D Fraser
Journal:  Pediatr Crit Care Med       Date:  2006-05       Impact factor: 3.624

Review 6.  Nutritional management of urea cycle disorders.

Authors:  Rani H Singh; William J Rhead; Wendy Smith; Brendan Lee; Lisa Sniderman King; Marshall Summar
Journal:  Crit Care Clin       Date:  2005-10       Impact factor: 3.598

7.  Late-onset ornithine transcarbamylase deficiency: a potentially fatal yet treatable cause of coma.

Authors:  David C Crosbie; Hariharan Sugumar; Marion A Simpson; Susan P Walker; Helen M Dewey; Michael C Reade
Journal:  Crit Care Resusc       Date:  2009-09       Impact factor: 2.159

8.  Hyperammonemia due to Adult-Onset N-Acetylglutamate Synthase Deficiency.

Authors:  Anne-Els van de Logt; Leo A J Kluijtmans; Marleen C D G Huigen; Mirian C H Janssen
Journal:  JIMD Rep       Date:  2016-05-05

9.  Fatal hyperammonaemia due to late-onset ornithine transcarbamylase deficiency.

Authors:  G P Bijvoet; C J M van der Sijs-Bos; J P M Wielders; O A Groot
Journal:  Neth J Med       Date:  2016-01       Impact factor: 1.422

10.  The incidence of urea cycle disorders.

Authors:  Marshall L Summar; Stefan Koelker; Debra Freedenberg; Cynthia Le Mons; Johannes Haberle; Hye-Seung Lee; Brian Kirmse
Journal:  Mol Genet Metab       Date:  2013-07-18       Impact factor: 4.797

View more
  6 in total

Review 1.  Nonhepatic Hyperammonemia With Septic Shock: Case and Review of Literature.

Authors:  Nishil Dalsania; Suhali Kundu; Ravi Karan Patti; Navjot Somal; Yizhak Kupfer
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

2.  Hyperammonaemic Encephalopathy Caused by Adult-Onset Ornithine Transcarbamylase Deficiency.

Authors:  Bjarke Hammer Niclasen; Maria Therese Schelde-Olesen; Mads Astvad; Anders Løkke; Thomas Krøigård; Helle H Nielsen
Journal:  Brain Sci       Date:  2022-02-08

3.  A 36-year-old Man with Repeated Short-term Transient Hyperammonemia and Impaired Consciousness with a Confirmed Carbamoyl Phosphate Synthase 1 Gene Monoallelic Mutation.

Authors:  Ruoyi Ishikawa; Takamichi Sugimoto; Takafumi Abe; Narumi Ohno; Taku Tazuma; Mayumi Giga; Hiroyuki Naito; Tomoyuki Kono; Eiichi Nomura; Keiichi Hara; Tohru Yorifuji; Takemori Yamawaki
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282

4.  Ornithine Transcarbamylase Deficiency Presenting as Acute Encephalopathy After Strabismus Surgery.

Authors:  John Lung; Sunil Sathappan; Isra Sabir; Richard Maier
Journal:  Cureus       Date:  2022-07-08

Review 5.  Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination.

Authors:  Ai-Ming Yu; Mei-Juan Tu
Journal:  Pharmacol Ther       Date:  2021-08-14       Impact factor: 13.400

Review 6.  Modelling urea cycle disorders using iPSCs.

Authors:  Claire Duff; Julien Baruteau
Journal:  NPJ Regen Med       Date:  2022-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.